Skip to content

Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise

Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise in Older Men With Osteosarcopenia A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04444661
Enrollment
21
Registered
2020-06-23
Start date
2020-06-10
Completion date
2020-12-31
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis, Sarcopenia

Brief summary

Osteosarcopenia designates the simultaneous presence of sarcopenia and osteopenia; both chronic conditions of advanced age. Dynamic-resistance exercise (DRT) might be the most powerful agent to fight osteosarcopenia. Indeed, in the present FrOST study, we clearly determine the positive effect of slightly adapted 18 month high-intensity (HIT)-DRT on bone mineral density (BMD), sarcopenia and other health related parameters in osteosarcopenic men. However, after a short training break, COVID-19 induced lock down prevented a re-start of the HIT resistance exercise training in the FrOST cohort. The aim of the present observational study is thus to determine the effects of 6 months of deconditioning on health related parameters under special regard of osteosarcopenia in this cohort of older men with osteosarcopenia.

Interventions

None listed

Sponsors

Friedrich-Alexander-Universität Erlangen-Nürnberg
CollaboratorOTHER
University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
74 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* participants of the FrOST study (NCT03453463)

Exclusion criteria

* medication and diseases with potential impact on study outcomes during the last 26 weeks.

Design outcomes

Primary

MeasureTime frameDescription
SMIChange from Baseline to 26 weeksSkeletal muscle mass index (appendicular skeletal muscle mass / body height; kg/m2) as determined by Dual Energy x-Ray Absorptiometry

Secondary

MeasureTime frameDescription
BMD-hipChange from Baseline to 26 weeksBone Mineral Density at the total hip as determined by Dual Energy x-Ray Absorptiometry
Sarcopenia-Z-ScoreChange from Baseline to 26 weeksZ-Score of parameters constituting the metabolic syndrome (i.e. SMI, hand-grip strength, gait velocity)
Fat infiltration thigh musclesChange from Baseline to 26 weeksIntramuscular adipose tissue at the mid thigh as determined by Magnetic Resonance Imaging
BMD-LSChange from Baseline to 26 weeksBone Mineral Density at the Lumbar Spine as determined by Dual Energy x-Ray Absorptiometry
Maximum hip-/leg extensor strengthChange from Baseline to 26 weeksMaximum hip-/leg extensor strength as determined by an isokinetic leg press
Metabolic Syndrome Z-ScoreChange from Baseline to 26 weeksMetabolic Syndrome Z-Score based on the definition of the International Diabetes Federation including waist circumference, resting glucose, HDL-cholesterol, triglyzerides, mean arterial blood pressure)
Self rated physical performanceChange from Baseline to 26 weeksLate-Life Function and Disability Index of McAuley et al.
Fat infiltration para-vertebral musclesChange from Baseline to 26 weeksIntramuscular adipose tissue at the mid thigh as determined by Magnetic Resonance Imaging

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026